Front Row Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-83
| Closed | -$12.9K | – | 533 |
|
|
2024
Q2 | $12.9K | Buy |
83
+2
| +2% | +$301 | ﹤0.01% | 508 |
|
|
2024
Q1 | $10.9K | Buy |
+81
| New | +$10.7K | ﹤0.01% | 560 |
|
|
2023
Q4 | – | Sell |
-91
| Closed | -$12.3K | – | 504 |
|
|
2023
Q3 | $12.3K | Buy |
91
+6
| +7% | +$819 | 0.01% | 473 |
|
|
2023
Q2 | $12K | Sell |
85
-13
| -13% | -$1.91K | 0.01% | 475 |
|
|
2023
Q1 | $14K | Buy |
98
+3
| +3% | +$404 | 0.01% | 443 |
|
|
2022
Q4 | $13K | Sell |
95
-29
| -23% | -$3.64K | 0.01% | 440 |
|
|
2022
Q3 | $14K | Sell |
124
-109
| -47% | -$13.8K | 0.01% | 440 |
|
|
2022
Q2 | $31K | Sell |
233
-26
| -10% | -$3.41K | 0.02% | 295 |
|
|
2022
Q1 | $34K | Buy |
259
+3
| +1% | +$360 | 0.01% | 307 |
|
|
2021
Q4 | $30K | Sell |
256
-10
| -4% | -$1.18K | 0.01% | 337 |
|
|
2021
Q3 | $32K | Buy |
266
+9
| +4% | +$1.05K | 0.01% | 320 |
|
|
2021
Q2 | $30K | Buy |
257
+114
| +80% | +$12.5K | 0.01% | 336 |
|
|
2021
Q1 | $14K | Buy |
143
+7
| +5% | +$704 | 0.01% | 472 |
|
|
2020
Q4 | $14K | Buy |
136
+6
| +5% | +$636 | 0.01% | 446 |
|
|
2020
Q3 | $14K | Buy |
130
+77
| +145% | +$8.56K | 0.01% | 436 |
|
|
2020
Q2 | $6K | Sell |
53
-2
| -4% | -$207 | ﹤0.01% | 573 |
|
|
2020
Q1 | $6K | Sell |
55
-4
| -7% | -$377 | ﹤0.01% | 562 |
|
|
2019
Q4 | $6K | Buy |
59
+8
| +16% | +$753 | ﹤0.01% | 567 |
|
|
2019
Q3 | $5K | Buy |
51
+25
| +96% | +$2.17K | ﹤0.01% | 580 |
|
|
2019
Q2 | $2K | Buy |
26
+8
| +44% | +$627 | ﹤0.01% | 807 |
|
|
2019
Q1 | $1K | Hold |
18
| – | – | ﹤0.01% | 928 |
|
|
2018
Q4 | $1K | Hold |
18
| – | – | ﹤0.01% | 903 |
|
|
2018
Q3 | $1 | Hold |
18
| – | – | ﹤0.01% | 874 |
|
|
2018
Q2 | $1 | Hold |
18
| – | – | ﹤0.01% | 923 |
|
|
2018
Q1 | $1K | Hold |
18
| – | – | ﹤0.01% | 857 |
|
|
2017
Q4 | $1K | Buy |
+18
| New | +$1.21K | ﹤0.01% | 746 |
|
Other funds holding AZN
